Invention Grant
- Patent Title: Anti-TIGIT antibody and use thereof
-
Application No.: US16965687Application Date: 2019-07-25
-
Publication No.: US11370837B2Publication Date: 2022-06-28
- Inventor: Xinzhen Shi , Pan Zhang , Junjian Liu
- Applicant: INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
- Applicant Address: CN Jiangsu
- Assignee: INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
- Current Assignee: INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
- Current Assignee Address: CN Jiangsu
- Agency: Leason Ellis LLP
- Priority: CN201810823583.6 20180725
- International Application: PCT/CN2019/097665 WO 20190725
- International Announcement: WO2020/020281 WO 20200130
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61P35/00 ; A61K47/68 ; C12N15/63 ; A61K31/713 ; G01N33/53 ; A61P31/12 ; A61P37/04 ; C07K14/705 ; A61K45/06
Abstract:
The present invention relates to a novel antibody and an antibody fragment thereof that specifically bind to TIGIT and a composition comprising the antibody or the antibody fragment. In addition, the present invention relates to a nucleic acid encoding the antibody or the antibody fragment thereof, a host cell comprising the nucleic acid, and related use. Furthermore, the present invention relates to therapeutic and diagnostic use of the antibody and the antibody fragment.
Public/Granted literature
- US20210040201A1 ANTI-TIGIT ANTIBODY AND USE THEREOF Public/Granted day:2021-02-11
Information query
